Immunophilin ligands decrease release of pro-inflammatory cytokines (IL-1β, TNF-α and IL-2) in rat astrocyte cultures exposed to simulated ischemia in vitro

Polish Journal of Pharmacology

Volumn 56, Issue 1, 2004, Pages 129-136

  Gabryel, Bozena ^a   Łabuzek, Krzysztof ^a   Małecki, Andrzej ^a   Herman, Zbigniew S ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Astrocytes; Cytokines; IL 1 ; IL 2; Immunophilin ligands; Ischemia; TNF

Indexed keywords

CYCLOSPORIN A; CYTOKINE; IMMUNOPHILIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; LEUCINE METHYL ESTER; LIGAND; RAPAMYCIN; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; GLIA CELL; IN VITRO STUDY; INCUBATION TIME; MICROGLIA; NEUROPROTECTION; NEWBORN; NONHUMAN; SIMULATION;

ANIMALS; ASTROCYTES; CELLS, CULTURED; CYCLOSPORINE; CYTOKINES; IMMUNOPHILINS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-2; ISCHEMIA; LIGANDS; NERVOUS SYSTEM; RATS; RATS, WISTAR; SIROLIMUS; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1942484941     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Aggarwal BB, Natarajan K: Tumor necrosis factor: developments during the last decade. Eur Cytokine Netw, 1996, 7, 93-124.
2. Balasingam V, Tejada-Berges T, Wright E: Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci, 1994, 14, 846-856.
3. Beneviste EN: Astrocyte-microglia interactions. In: Astrocytes: Pharmacology and Function. Ed. Murphy S, Academic Press, San Diego, 1993, 355-383.
4. Butcher SP, Henshall DC, Teramura Y, Iwasaki K, Sharkey J: Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J Neurosci, 1997, 17, 6939-6946.
5. Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC: Inflammatory cytokines IL-1α, IL-1β, IL-6, and TNF-α impart neuroprotection to an excitotoxin through distinct pathways. J Immunol, 1999, 129, 3963-3968.
6. Chao CC, Gekker G, Hu S, Sheng WS, Portoghese PS, Peterson PK: Upregulation of HIV-1 expression in co-cultures of chronically infected promonocytes and human brain cells by dynorphin. Biochem Pharmacol, 1995, 50, 715-722.
7. Charters AR, Kobayashi M, Butcher SP: The subcellular distribution of FK506 binding proteins in rat brain. Biochem Soc Trans, 1994, 22, 412S.
8. Chung IY, Benveniste EN: Tumor necrosis factor-alpha production by astrocytes: induction by lipopolysaccharide, interferon-gamma and interleukin-1. J Immunol, 1990, 144, 2999-3007.
9. Ciechomska I, Pyrzyńska B, Kaźmierczak P, Kamińska B: Inhibition of Akt kinase signaling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells. Oncogene, 2003, 23, 7617-7627.
10. Dawson VL, Kizushi VM, Huang PL, Snyder SH, Dawson TM: Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci, 1996, 16, 2476-2487.
11. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C: Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia, 1993, 7, 75-83.
12. Dong Y, Benveniste EN: Immune function of astrocytes. Glia, 2001, 36, 180-190.
13. Dumont FJ, Melino MR, Staruch MJ, Koprak SL, Fischer PA, Signal NH: The immunossuppressive macrolides FK506 and rapamycin act as reciprocal antagonists in murine T cells. J Immunol, 1990, 144, 1418-1424.
14. Eizenberg O, Faber-Elman A, Lotan M, Schwartz M: Interleukin-2 transcripts in human and rodent brains: possible expression by astrocytes. J Neurochem, 1995, 64, 1928-1936.
15. Frohman EM, Frohman TC, Dustin ML, Vayuvegula B, Choi B, Gupta A, van den Noort S, Gupta S: The induction of intracellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-γ, tumor necrosis factor-α, lyinphotoxin, and interleukin-1: relevance to intracerebral antigen presentation. J Neuroimmunol, 1989, 23, 117-124.
16. Gabryel B, Adamczyk J, Huzarska M, Pudełko A, Herman ZS: Aniracetam attenuates apoptosis of astrocytes subjected to simulated ischemia in vitro. Neurotoxicology, 2002, 23, 385-395.
17. Gabryel B, Trzeciak HI: Role of astrocytes in pathogenesis of ischemic brain injury. Neurotoxicity Res, 2001, 3, 205-221.
18. Gijbels K, Van-Damme J, Proost P, Put W, Carton H, Billiau AA: Interleukin-6 production in the central nervous system during experimental autoimmune encephalomyelitis, Eur J Immunol, 1990, 20, 233-235.
19. Hariri RJ, Chang VA, Barie PS: Traumatic injury induces interleukin-6 production by human astrocytes. Brain Res, 1994, 636, 139-142.
20. Hashimoto T, Kawamata T, Saito N, Sasaki M, Nakai M, Niu S, Taniguchi T et al.: Isoform-specific redistribution of calcineurin A alpha and A beta in the hippocampal CA1 region of gerbils after transient ischemia. J Neurochem, 1998, 70, 1289-1298.
21. Herdegen T, Fischer G, Gold BG: Immunophilin ligands as novel treatment for neurological disorders. Trends Pharmacol Sci, 2000, 21, 3-5.
22. Hertz L, Juurlink BHJ, Szuchet S: Cell cultures. In: Handbook of Neurochemistry. Ed. Lajtha A, Plenum Press, New York, 1985, Vol. 8, 603-661.
23. Hofman FM, Hinton DR, Johnson K, Merill JE: Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med, 1989, 170, 607-612.
24. Ivery MT, Weiler L: Modeling the interaction between FK506 and FKBP12: a mechanisms for formation of the calcineurin inhibitory complex. Bioorg Med Chem, 1997, 5, 217-232.
25. Kim JS: Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci, 1996, 137, 69-78.
26. Koenig J, Snow K, Clarc BC, Toni R, Cannon JG, Shaw Alt, Dinarello CA et al.: Intrinsic pituitary interleukin-1β induced by bacterial lipopolysaccharide. Endocrinology, 1990, 126, 3053-3058.
27. Lau LT, Yu AC: Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alfa and interferon-gamma following traumatic and metabolic injury. J Neurotrauma, 2001, 18, 351-359.
28. Lyons WE, Steiner JP, Snyder SH, Dawson TM: Neuronal regeneration enhances the expression of the immunophilin FKBP-12. J Neurosci, 1995, 15, 2985-2994.
29. Maeda Y, Matsumoto M, Hori O: Hypoxia/reoxygenation-mediated induction of astrocyte interleukin-6: a paracrine mechanism potentially enhancing neuron survival. J Exp Med, 1994, 180, 2297-2308.
30. Marks AR: Cellular functions of immunophilins. Physiol Rev, 1996, 76, 631-649.
31. 2+ paradox like injury of cultured rat astrocytes. J Neurochem, 1998, 70, 2004-2011.
32. McDonald JW, Goldberg MP, Gwag BJ, Chi SI, Choi DW: Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures. Ann Neurol, 1996, 40, 750-758.
33. Merrill JE: Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J Immunother, 1992, 12, 167-170.
34. Mizuno M, Yoshida J: Tumor necrosis factor-alfa gene transfer augments anti-Fas antibody-mediated apoptosis in human glioma cells. Jpn J Cancer Res, 1996, 87, 543-547.
35. Mogi M, Harada M, Kondo T, Riederer P, Imagaki H, Minami M, Nagatsu T: Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients. Neurosci Lett, 1994, 180, 147-150.
36. Mosieniak G, Figiel I, Kamińska B: Cyclosporin A, an immunosuppressive drug, induces programmed cell death in rat C6 glioma by a mechanism that involves the AP-1 transcription factor. J Neurochem, 1997, 68, 1142-1149.
37. Muramoto M, Yamazaki T, Nishimura S, Kita Y. Detailed in vitro pharmacological analysis of FK506-induced neuroprotection. Neuropharmacology, 2003, 45, 394-403.
38. Obeid LM, Linardic CM, Karolak LA, Hannun Y: Programmed cell death induced by ceramide. Science, 1993, 259, 1769-1771.
39. Rao A, Luo C, Hogan PG: Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol, 1997, 15, 707-747.
40. Reisman L, Lin WG, Martinelli GP: Modulation of interleukin-1 secretion by immunosuppressive drugs, alone and in combination. Transpl Immunol, 1995, 3, 45-49.
41. Relton JK, Rothwell NJ: Interleukin-1 receptor antagonists inhibit ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull, 1992, 29, 243-246.
42. Reyman KG, Schmidt W, Striggow F, Reiser G: Immunophilins in the CNS - potential targets for neuroprotective processes in the brain after cerebral ischemia. Restor Neurol Neurosci, 2000, 16, 33.
43. Saito K, Suyama K, Nishida K, Basile AS: Early increases in TNF-alfa, IL-6 and IL- beta levels following transient cerebral ischemia in gerbil brain. Neurosci Lett, 1996, 206, 149-452.
44. Sakuma S, Kato Y, Nishigaki F, Sasakawa T, Magari K, Miyata S, Ohkubo Y, Goto T: FK506 potently inhibits T cell activation induced TNF-α and IL-1beta production in vitro by human peripheral blood mononuclear cells. Br J Pharmacol, 2000, 130, 1655-1663.
45. Shinoda M, Sakabe K, Matsumae M, Shibata M, Tsugu A, Katano Y, Tsugane R: Inummosuppressive therapy with FK506 as a model of traumatic brain injury. Restor Neurol Neurosci, 2000, 16, 17-18.
46. Simmons ML, Murphy S: Induction of nitric oxide synthase in glial cells. J Neurochem, 1992, 59, 897-905.
47. Takuma F, Fujita T, Kimura Y, Tanabe M, Yamamuro A, Lee E, Mori K et al.: T-588 inhibits astrocyte apoptosis via mitogen-activated protein kinase signal pathway. Eur J Pharmacol, 2000, 399, 1-8.
48. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DE: Cytoldne expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol, 1992, 31, 349-360.
49. Uchino H, Elmer E, Uchino K, Lindvall O, Siesjo BK: Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischemia in the rat. Acta Physiol Scand, 1995, 155, 469-471.
50. Viviani B, Marinovich M: Neurotoxicity: an active role for glia? Neurosci Res Commun 1998, 23, 1-12.
51. Wesselborg S, Fruman DA, Sagoo JY, Bierer BE, Burakoff SJ: Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp). J Biol Chem, 1996, 27, 1274-1277.
52. Zawadzka M, Kamińska. B: Immunosuppressant FK506 affects multiple signaling pathways and modulates gene expression in astrocytes. Mol Cell Neurosci, 2003, 22, 202-209.